These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 1561384)

  • 21. [Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
    Olier B; Morin JP; Thomas N; Fillastre JP
    Pathol Biol (Paris); 1988 Jun; 36(6):795-800. PubMed ID: 3047639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Campoli-Richards DM; Chaplin S; Sayce RH; Goa KL
    Drugs; 1989 Nov; 38(5):703-56. PubMed ID: 2689137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?
    Nordström L; Ringberg H; Cronberg S; Tjernström O; Walder M
    J Antimicrob Chemother; 1990 Jan; 25(1):159-73. PubMed ID: 2108113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once-daily gentamicin versus once-daily netilmicin in patients with serious infections--a randomized clinical trial.
    Prins JM; Büller HR; Kuijper EJ; Tange RA; Speelman P
    J Antimicrob Chemother; 1994 Apr; 33(4):823-35. PubMed ID: 8056701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing.
    Kim MJ; Bertino JS; Erb TA; Jenkins PL; Nafziger AN
    J Clin Pharmacol; 2004 Jul; 44(7):696-707. PubMed ID: 15199074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients.
    Rozdzinski E; Kern WV; Reichle A; Moritz T; Schmeiser T; Gaus W; Kurrle E
    J Antimicrob Chemother; 1993 Apr; 31(4):585-98. PubMed ID: 8514653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?
    Barclay ML; Kirkpatrick CM; Begg EJ
    Clin Pharmacokinet; 1999 Feb; 36(2):89-98. PubMed ID: 10092956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services.
    Mathews A; Bailie GR
    J Clin Pharm Ther; 1987 Oct; 12(5):273-91. PubMed ID: 3119606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative dosing strategy for aminoglycosides: impact on efficacy, nephrotoxicity, and ototoxicity.
    Chan GL
    DICP; 1989 Oct; 23(10):788-94. PubMed ID: 2683419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminoglycoside nephrotoxicity: modeling, simulation, and control.
    Rougier F; Claude D; Maurin M; Sedoglavic A; Ducher M; Corvaisier S; Jelliffe R; Maire P
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1010-6. PubMed ID: 12604535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.
    Boyer A; Gruson D; Bouchet S; Clouzeau B; Hoang-Nam B; Vargas F; Gilles H; Molimard M; Rogues AM; Moore N
    Drug Saf; 2013 Apr; 36(4):217-30. PubMed ID: 23508544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single daily dose therapy with aminoglycosides.
    Nordström L; Lerner SA
    J Hosp Infect; 1991 Jun; 18 Suppl A():117-29. PubMed ID: 1679774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminoglycosides use in patients over 75 years old.
    Fraisse T; Gras Aygon C; Paccalin M; Vitrat V; De Wazieres B; Baudoux V; Lechiche C; Vicens A; Sotto A; Pagani L; Gaillat J; Forestier E; Gavazzi G
    Age Ageing; 2014 Sep; 43(5):676-81. PubMed ID: 24590569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and safety of once-daily aminoglycosides: a meta-analysis.
    Ferriols-Lisart R; Alós-Almiñana M
    Am J Health Syst Pharm; 1996 May; 53(10):1141-50. PubMed ID: 8734674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of once-daily netilmicin to treat infants with suspected sepsis in a neonatal intensive care unit.
    Brooks JR; Marlow N; Reeves BC; Millar MR
    Biol Neonate; 2004; 86(3):170-5. PubMed ID: 15237240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended dosage intervals for aminoglycosides.
    Rodman DP; Maxwell AJ; McKnight JT
    Am J Hosp Pharm; 1994 Aug; 51(16):2016-21. PubMed ID: 7977422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.
    Rao SC; Ahmed M; Hagan R
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005091. PubMed ID: 16437518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once-daily dosing of aminoglycoside antibiotics.
    Fisman DN; Kaye KM
    Infect Dis Clin North Am; 2000 Jun; 14(2):475-87. PubMed ID: 10829267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.